AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F942-F949, 2008. First published August 27, 2008; doi:10.1152/ajprenal.90236.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/F942    most recent
90236.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, H.
Right arrow Articles by Yang, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, H.
Right arrow Articles by Yang, T.

Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury

Haiying Liu,1,2 Zhunjun Jia,1 Sunhapas Soodvilai,1 Guangju Guan,2 Mong-Heng Wang,3 Zheng Dong,4,5 J. David Symons,1,6 and Tianxin Yang1

1Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, Salt Lake City; 2Department of Nephrology, 2nd Affiliated Hospital, Shandong University, Jinan, China; Departments of 3Physiology and 4Cellular Biology and Anatomy, Medical College of Georgia, and 5Medical Research Service, Veterans Affairs Medical Center, Augusta, Georgia; and 6College of Health University of Utah, Salt Lake City, Utah

Submitted 3 April 2008 ; accepted in final form 9 June 2008

Nitroalkene derivatives of linoleic acid (nitrolinoleic acid; LNO2) and nitro-oleic acid (OA-NO2) are endogenous lipid products with potent anti-inflammatory properties. The present study was undertaken to evaluate the therapeutic potential of OA-NO2 in a mouse model of renal ischemia-reperfusion (I/R) injury. B6129SF2/J mice were subjected to bilateral renal ischemia for 30 min, followed by 24 h of reperfusion. Fifty minutes after ischemia, mice received intraperitoneal (ip) injections of OA-NO2 (500 µg/kg; I/R OA-NO2), vehicle for OA-NO2 (i.e., 0.8 ml/kg ethanol; I/R veh), or oleic acid (500 µg/kg; I/R OA) every 6 h during the 24-h recovery period. A sham-operated group was not subjected to ischemia and received 0.8 ml/kg ethanol ip every 6 h during the 24-h recovery period (sham veh). While plasma urea and creatinine were elevated (P < 0.05) in I/R veh vs. sham veh mice, the severity was less (P < 0.05) in I/R OA-NO2 animals. Indices of histological damage, polymorphonucleocyte infiltration, together with expression of intracellular adhesion molecule-1, interleukin-1β, and tumor necrosis factor-{alpha}, p47phox, and gp91phox were greater in I/R veh vs. sham veh mice, but were attenuated (P < 0.05) in I/R OA-NO2 animals. Because indices of renal dysfunction were similar between I/R veh and I/R OA mice (P > 0.05), but less (P < 0.05) in I/R OA-NO2 animals compared with both groups, protection from bilateral renal ischemia is afforded by the nitrated but not free form of oleic acid. Together, delayed administration of nitrated fatty acid OA-NO2 attenuates renal I/R injury in the mouse likely via inhibition of the inflammatory response.

nitrated fatty acids; acute renal failure; inflammation



Address for reprint requests and other correspondence: T. Yang, Univ. of Utah and Veteran Affairs Medical Center, Div. of Nephrology and Hypertension, 30 N 1900 E, Rm. 4R312, Salt Lake City, UT 84132 (e-mail: Tianxin.Yang{at}hsc.utah.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.